1193 / 1345
132 101 69 43 29 16 5 1
97 78 69 46 29 12 3 0
115 85 64 46 32 19 6 1
86 57 46 32 25 15 4 2
Frequency G≥2 and
EMBRACE I cohort
5 centers included
Patients with Bladder wall infiltration excluded
Patients with Baseline morbidity assessment
and at least one Follow Up included
451 patients
CTC Grade
0
172
1
213
2
50
3
4
ICRU bladder point dose
representing bladder trigonum dose
Dose constraint:
<76 Gy
Up to 12% G≥2
Work in progress:
Spampinato, Tanderup et al. Work in progress